TONIX PHARMACEUTICALS HOLDING CORP Inactive Instrument
Calendar Tonix Pharmaceuticals Holding Corp OTC Bulletin Board
Equities
TNXP
US8902601025
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-09 | Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge | MT |
| 07-09 | Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding | CI |
Chart calendar Tonix Pharmaceuticals Holding Corp
cd0496f454e551a637dbedf6.V5dZKA56pEZS6idaRwVHyHMhlt3_s2xkv5795GoQk2w.A-IfT3Q3kh8NqWZjCGcTpCpr9ZKP8SoNi_-T0w5axzg5r254YAiXBGOcZg~af1002d3077717c7078c6526856015b2
Upcoming events on Tonix Pharmaceuticals Holding Corp
Past events on Tonix Pharmaceuticals Holding Corp
| 14/06/2024 11:36 | European Alliance of Associations for Rheumatology Congress - Abstract No : POS0324 |
| 11/06/2024 | Rheumatology European Congress |
| 09/06/2024 | Reverse Split: 1 of 32 |
| 09/06/2024 | Reverse Split: 1 of 32 |
| 04/06/2024 18:45 | BIO International Convention |
| 04/06/2024 15:15 | American Transplant Congress - Extended Survival of 9- and 10-Gene-Edited Pig Heart Xenografts with |
| 04/06/2024 14:45 | American Transplant Congress - Combined Blockade of the CD154 and CD28 Co-Stimulation Pathways Atten |
| 03/06/2024 14:15 | American Transplant Congress - Abstract Number: C086 |
| 31/05/2024 | American Transplant Congress |
| 30/05/2024 17:30 | American Society of Clinical Psychopharmacology Meeting |
| 29/05/2024 20:00 | American Society of Clinical Psychopharmacology Meeting |
| 22/05/2024 16:00 | Annual General Meeting |
| 21/05/2024 14:00 | Alliance Global Partners Healthcare Showcase |
| 13/05/2024 21:30 | Q1 2024 Earnings Release |
| 01/05/2024 16:00 | Planet MicroCap Showcase |
| 01/04/2024 21:15 | Q4 2023 Earnings Release |
| 19/03/2024 09:45 | BioEurope Spring Conference |
| 16/03/2024 | American Chemistry Society Spring Meeting |
| 06/03/2024 | Controversies in Fibromyalgia International Congress |
| 03/03/2024 | Investor Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 7,77 10,3 -24.56% | 13,9 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -28,8 -26,4 -9% | -50,5 -48,0 -5.24% | -92,3 -88,1 -4.82% | -112 -109 -2.59% | -118 -118 -0.45% | -80,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,6 -26,2 -9.23% | -50,5 -47,3 -6.69% | -92,3 -92,7 0.45% | -110 -110 -0.2% | -117 -119 1.89% | -117 |
|
Net income Million USD | Released Forecast Spread | -31,1 -26,3 -18.25% | -52,2 -48,7 -7.03% | -92,3 -88,0 -4.92% | -117 -111 -5.76% | -117 -115 -1.05% | -79,8 |
|
EPS USD | Released Forecast Spread | -123 712 -99 520 -24.31% | -3 520 -3 040 -15.79% | -1 664 -1 568 -6.12% | -654 -775 15.58% | -219 -268 18.16% | -30,6 |
| Announcement Date | 24/03/20 | 15/03/21 | 14/03/22 | 13/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 3,99 5,80 -31.22% | 3,78 5,13 -26.38% | 2,48 3,87 -35.81% | 3,35 | 3,48 | 3,95 | 4,10 | 4,65 |
|
EBIT Million USD | Released Forecast Spread | -26,4 -24,1 -9.69% | -23,3 -26,5 11.94% | -29,6 -29,0 -2.04% | -32,7 -29,9 -9.55% | -33,9 -29,0 -16.9% | -29,0 -30,0 3.33% | -28,1 -25,1 -12.07% | -27,3 -26,8 -2.07% | -21,4 -28,6 25.35% | -21,2 | -19,0 | -18,9 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,4 -24,1 -9.61% | -23,1 -26,5 12.68% | -29,0 -29,0 0.07% | -31,7 -31,5 -0.57% | -33,0 -28,0 -17.88% | -28,4 -29,2 2.89% | -28,0 -28,3 1.15% | -27,3 -29,6 7.7% | -14,9 -28,5 47.58% | -28,9 | -29,4 | -30,4 | ||
|
Net income Million USD | Released Forecast Spread | -26,4 -24,1 -9.61% | -27,4 -26,5 -3.38% | -29,0 -29,0 0.07% | -34,1 -31,5 -8.2% | -33,0 -28,0 -17.88% | -28,4 -29,3 3.22% | -28,0 -24,5 -14.11% | -27,3 -26,1 -4.58% | -14,9 -28,5 47.58% | -20,8 | -18,6 | -18,5 | ||
|
EPS USD | Released Forecast Spread | -320 -299 -7.14% | -244 -289 15.57% | -138 -204 32.35% | -112 -172 34.88% | -104 -96,7 -7.59% | -85,8 -64,7 -32.45% | -58,6 -47,7 -22.82% | 17,6 -46,8 137.59% | -5,76 -10,9 47.06% | -7,20 | -6,40 | -6,56 | -5,44 | -5,44 |
| Announcement Date | 09/05/22 | 08/08/22 | 07/11/22 | 13/03/23 | 08/05/23 | 10/08/23 | 09/11/23 | 01/04/24 | 13/05/24 | - | - | - | - | - |
| 23/07/2024 07:00 | BIOGAIA AB: Q2 2024 Earnings Release |
| 23/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 06:00 | UCB: Q2 2024 Earnings Release |
| 25/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release |
| 29/07/2024 | BIOTEST AG: Q2 2024 Earnings Release |
| 30/07/2024 12:00 | INCYTE CORPORATION: Q2 2024 Earnings Release |
| 30/07/2024 | VERICEL CORPORATION: Q2 2024 Earnings Release (Projected) |
Past sector events for Tonix Pharmaceuticals Holding Corp
| 15/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 11/07/2024 11:30 | KALVISTA PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 11/07/2024 07:00 | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 23/05/2024 10:43 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
| 15/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 14/05/2024 16:35 | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 13/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
| 09/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- TNXP Stock
- TNXP Stock
- Calendar Tonix Pharmaceuticals Holding Corp
